Danger: Is AI making the first consultation a second opinion?

Tuesday November 17th, 2026 - 11am EST, 4pm GMT, 5pm CET

Register Now

Cheap testing and fast AI answers provide unprecedented accessibility, but they do not inherently improve patient outcomes… and can sometimes worsen them.

Many patients now arrive at their first appointment with home-collected test results and an AI-generated interpretation already in hand. Patient-centric sampling and conversational AI have made diagnostics more accessible than ever, but access alone does not improve outcomes. Results without context can create false reassurance, unnecessary anxiety or delayed care. Drawing on fertility care as an example of complex care pathways, this panel discusses how remote diagnostics, lab innovation, and AI can be used to redesign integrated patient journeys and improve the outcomes that matter for both patients and clinicians.

What you will learn

  • Remote diagnostics: what patients told us about capillary versus venous sampling, and what labs need before they trust a sample collected at home
  • Data, decisions and dangers: when cheap tests and AI chatbot answers help patients, and when they cause false reassurance, anxiety or delay
  • Interpretation vs diagnosis: where explaining a result ends and diagnosing begins, and who is accountable when AI gets it wrong
  • Unblocking the journey: what is really stopping remote diagnostics becoming routine, and how telemedicine and well-governed AI can improve outcomes today

Speakers

Andreia Trigo BSc MSc RN ANP

Co-Founder and Chief Executive Officer, Enhanced Fertility and EnhancedDx

Andreia Trigo is Chief Executive Officer and Clinical Director of EnhancedDx. An Advanced Nurse Practitioner with more than 20 years of nursing experience across perioperative care, pain medicine and clinical research, she founded Enhanced Fertility in 2020 to improve access to personalised fertility care through data, AI and remote diagnostics. She previously led mHealth research on patient-reported outcomes at University College London Hospitals and taught on De Montfort University’s MSc in Advanced Practice. A TEDx speaker and recipient of King’s College London’s Distinguished Alumni Entrepreneurship Award, she is a member of the British Fertility Society, American Society for Reproductive Medicine and the European Society for Human Reproduction & Embryology.

Carlos Sousa PhD

Molecular Biology Director, SYNLAB Portugal

Carlos Rafael Sousa is Molecular Biology Director at SYNLAB Portugal, based in Porto. A microbiologist with more than 25 years in molecular diagnostics, he has led molecular biology laboratories in pathology and clinical settings, with particular expertise in high-risk HPV detection, molecular microbiology, virology and research into host DNA methylation in cervical cancer. He has extensive experience implementing and maintaining ISO 15189 and ISO 9001 quality systems, giving him a practical view of what laboratories need before they can validate and trust new sample types and testing pathways.

Carol Lynn Curchoe PhD, HCLD

Director of Science and Innovation, Progenesis

Carol Lynn Curchoe is a reproductive physiologist and High Complexity Laboratory Director who builds and directs IVF laboratories. She is currently the Director of Science and Innovation at Progenesis, where she integrates genetics, AI-driven analytics, EMR systems and connected laboratory technologies, and has served as an IVF Laboratory Director for multiple leading US clinics. She chaired the American Society for Reproductive Medicine’s Artificial Intelligence Special Interest Group from 2023 to 2024 and founded ART Compass, a quality management platform for IVF laboratories. A former Utah State Science Advisor, author and expert in genetics and laboratory innovation.

Frank Khan Sullivan

Co-Founder and Chief Technology Officer, EnhancedDx

Frank Khan Sullivan is Co-Founder and Chief Technology Officer of Enhanced Fertility and EnhancedDx, and the original architect of the EnhancedDx clinical AI platform, which connects remote testing, laboratory results and clinical decision support. He designed the Open Patient Summary Record to give patients control and portability of their clinical data, and previously co-founded a cardiac and respiratory diagnostics clinic in the UK. His earlier career includes Microsoft, Rackspace and leading data at CSO at Publicis Groupe UK until 2022. He has served as a guest lecturer and executive MBA mentor at ESSEC Business School in Paris, and is an allied member of ASRM and ESHRE with experience in informatics and artificial intelligence.

Neil Spooner

Director Spooner Bioanalytical Solutions & Chair Patient Centric Sampling Interest Group

Neil is the Founder of Spooner Bioanalytical Solutions, helping companies to integrate biological fluid microsampling, and patient centric sampling and analysis into workflows. He also works with organizations to develop technologies and introduce them to the market. Neil also assists organizations with their understanding of emerging trends in the pharmaceutical industry and bioanalysis. Neil is a Senior Visiting Research Fellow at the University of Hertfordshire, Editor in Chief of the journal, Bioanalysis, Founder of the Patient Centric Sampling Interest Group and Co-Chair of the Reid Bioanalytical Forum. He has published over 70 peer reviewed manuscripts and delivered over 50 podium presentations.​​​​​​​

In association with